Intermediate for Tofacitinib. Tofacitinib (trade name Xeljanz, Jakvinus) is a janus kinase (JAK) inhibitor for the treatment of rheumatoid arthritis (RA). Tofacitinib has been approved by the U.S Food and Drug Administration in November 2012.


Product Name:                  4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine?

Synonyms:                         N/A

CAS Number:                     479633-63-1

Molecular Weight:            307.7539

Molecular Formula:          C13H10ClN3O2S

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               Cc1ccc(cc1)S(=O)(=O)n1ccc2c1ncnc2Cl

  • $138.00
  • Ex Tax: $138.00

Available Options